555 related articles for article (PubMed ID: 1709437)
21. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).
Galetta D; Giotta F; Rosati G; Gebbia V; Manzione L; Di Bisceglie M; Borsellino N; Colucci G
Anticancer Res; 2005; 25(6C):4445-9. PubMed ID: 16334124
[TBL] [Abstract][Full Text] [Related]
23. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
[TBL] [Abstract][Full Text] [Related]
24. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.
Hanauske AR; Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Bochtler H; Diergarten K; Rastetter J
Semin Oncol; 1995 Dec; 22(6 Suppl 14):35-9. PubMed ID: 8553082
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.
Hussain M; Salwen W; Kucuk O; Ensley J
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-43-S19-45. PubMed ID: 9427265
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin and 5-fluorouracil for metastatic squamous cell carcinoma from unknown primary.
Khansur T; Allred C; Little D; Anand V
Cancer Invest; 1995; 13(3):263-6. PubMed ID: 7743377
[TBL] [Abstract][Full Text] [Related]
27. [Role of neoadjuvant chemotherapy in the treatment of advanced head and neck tumors. Results of two randomized therapeutical trials conducted at the Institut Curie on 208 patients].
Brunin F; Rodriguez J; Jaulerry C; Mosseri V; Jouve M; Point D; Asselain B; Validire P; Blaszka B; Zafrani B
Bull Cancer; 1992; 79(9):893-904. PubMed ID: 1283088
[TBL] [Abstract][Full Text] [Related]
28. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
[TBL] [Abstract][Full Text] [Related]
29. [Factors modifying remission in cytostatic chemotherapy of squamous cell carcinoma recurrence in the area of the head and neck].
Scherlacher A; Jakse R; Lehnert M; Haas J
Laryngorhinootologie; 1989 Aug; 68(8):425-32. PubMed ID: 2476996
[TBL] [Abstract][Full Text] [Related]
30. [Retrospective study of 139 cases of epidermoid carcinoma of the upper respiratory and digestive tracts treated by induction chemotherapy with cisplatin-5FU. Influence of the result on the therapeutic protocol].
Mahé E; Filleul A; Sachwald J; Meeus L; Bertrand F; Berlie J; Banal A; Zojaji A; Tubiana-Hulin M
Ann Otolaryngol Chir Cervicofac; 1992; 109(8):410-6. PubMed ID: 1304101
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomas.
Guillot T; Spielmann M; Kac J; Luboinski B; Tellez-Bernal E; Munck JN; Bachouchi M; Armand JP; Cvitkovic E
Laryngoscope; 1992 Mar; 102(3):311-9. PubMed ID: 1372059
[TBL] [Abstract][Full Text] [Related]
32. Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Bourhis J; Rivera F; Mesia R; Awada A; Geoffrois L; Borel C; Humblet Y; Lopez-Pousa A; Hitt R; Vega Villegas ME; Duck L; Rosine D; Amellal N; Schueler A; Harstrick A
J Clin Oncol; 2006 Jun; 24(18):2866-72. PubMed ID: 16717293
[TBL] [Abstract][Full Text] [Related]
33. Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kang HJ; Kim WK; Lee JS; Kang YK
Jpn J Clin Oncol; 2007 Jan; 37(1):30-7. PubMed ID: 17272321
[TBL] [Abstract][Full Text] [Related]
34. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.
Clavel M; Vermorken JB; Cognetti F; Cappelaere P; de Mulder PH; Schornagel JH; Tueni EA; Verweij J; Wildiers J; Clerico M
Ann Oncol; 1994 Jul; 5(6):521-6. PubMed ID: 7522527
[TBL] [Abstract][Full Text] [Related]
35. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.
Cho H; Nishiike S; Yamamoto Y; Takenaka Y; Nakahara S; Yasui T; Hanamoto A; Inohara H
Auris Nasus Larynx; 2015 Oct; 42(5):396-400. PubMed ID: 25721854
[TBL] [Abstract][Full Text] [Related]
36. [The efficacy of polychemotherapy with cisplatin, methotrexate and 5-fluorouracil in inoperable forms of squamous cell cancer of the head and neck area].
Karaseva VV; Stepanov VG; Korolev VV
Vopr Onkol; 1992; 38(2):205-8. PubMed ID: 1300707
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma.
Tellez-Bernal E; Belehradek M; Recondo G; Cvitkovic E; Leridant AM; Vericel R; Armand JP
Am J Clin Oncol; 1990 Oct; 13(5):452-4. PubMed ID: 1699403
[TBL] [Abstract][Full Text] [Related]
39. Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neck.
Merlano M; Rosso R; Sertoli MR; Benasso M; Bacigalupo A; Ardizzoni A; Mereu P; Margarino G; Scala M; Vitale V
Laryngoscope; 1990 May; 100(5):531-5. PubMed ID: 1691811
[TBL] [Abstract][Full Text] [Related]
40. [Multivariate analysis of the prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53].
Seitz JF; Perrier H; Monges G; Giovannini M; Gouvernet J
Gastroenterol Clin Biol; 1995 May; 19(5):465-74. PubMed ID: 7589997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
